Communication
Press releases
- 30/07/2010 First Half 2010 in line with guidance, strong R&D catalysts expected in second half
- 28/07/2010 Sativex® receives regulatory authorisation in Spain
- 26/07/2010 Almirall signs a co-promotion agreement with Pfizer to commercialise Conbriza® in Spain, a new therapeutic option to treat osteoporosis
- 23/07/2010 Almirall reaffirms its commitment to the environment with renewal of its ISO 14001:2004 certificate
Optimized for Internet Explorer